3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.

As shown in Fig 3 , there is a clear trend towards a dose-dependent decrease in migration cells after C35 treatment in both H1299 and Lewis cells.

also in 19,460 other papers